ABNORMAL DNA METHYLATION

This adverse event was reported 8 times

ABNORMAL DNA METHYLATION is most prevalent among patients taking these drugs:

# Drug Count Frequency
0 BLEOMYCIN SULFATE 5 0.0005
1 LANTHANUM CARBONATE 1 0.0002
2 DACARBAZINE 1 0.0001
3 ETOPOSIDE 4 0.0001
4 RIVASTIGMINE 1 0.0001
5 CISPLATIN 4 0.0001
6 CIPROFLOXACIN HYDROCHLORIDE AND HYDROCORTISONE 1 0.0000
7 MULTIVITAMIN 1 0.0000
8 CIPROFLOXACIN HYDROCHLORIDE 1 0.0000
9 MYCOPHENOLATE MOFETIL 1 0.0000
See all drugs enriched for association with ABNORMAL DNA METHYLATION

ABNORMAL DNA METHYLATION is most prevalent among patients taking these drug classes:

# Drug class Count Frequency
0 Cholinesterase Inhibitor [EPC] 1 0.0001
1 Topoisomerase Inhibitor [EPC] 4 0.0001
2 Folate Analog [EPC] 1 0.0000
3 Vitamin A [EPC] 1 0.0000
4 Nicotinic Acid [EPC] 1 0.0000
5 Antidote [EPC] 1 0.0000
6 Platinum-based Drug [EPC] 4 0.0000
7 Non-Standardized Food Allergenic Extract [EPC] 1 0.0000
8 Alkylating Drug [EPC] 1 0.0000
9 Vitamin D [EPC] 1 0.0000
See all drug classes enriched for association with ABNORMAL DNA METHYLATION